Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity-Reference-Cited by-同舟云学术

Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity

Published:2023-09 Issue:3 Volume:62 Page:106887
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Agyeman Akosua A.,López-Causapé Carla,Rogers Kate E.,Lucas Deanna Deveson,Cortés-Lara Sara,Gomis-Font Maria A.,Fraile-Ribot Pablo,Figuerola Joan,Lang Yinzhi,Franklyn Eva R.T.,Lee Wee Leng,Zhou Jieqiang,Zhang Yongzhen,Bulitta Jurgen B.,Boyce John D.,Nation Roger L.,Oliver Antonio,Landersdorfer Cornelia B.

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference59 articles.

1. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents—how P. aeruginosa can escape antibiotics;Ciofu;Front Microbiol,2019

2. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection;Oliver;Science,2000

3. Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs—a review;Sousa;Pathogens,2014

4. Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators;Lujan;PLoS One,2011

5. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis;Stefani;Int J Med Microbiol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa;Pharmaceuticals;2024-06-12

2. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing;International Journal of Antimicrobial Agents;2024-06

3. Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa;Antimicrobial Agents and Chemotherapy;2024-04-03